Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Deaths reported in Lebanon as Israel and Hezbollah exchange attacks - 2Nestlé recalls infant formula in 49 countries. See list.
- 3Hamas Navy head, engineer of Khan Yunis tunnel network killed in Gaza, IDF confirms
- 4Europe’s Airlines Run Low on Fuel
- 54 Famous Gaming PCs of 2024: Execution, Versatility, and Advancement
- Benihana is 60 years old. Gen Z is lining up.
- From Novice to Master: Dominating a Side interest
- Vote in favor of your Favored Kind of Scarf
- Pick Your #1 Japanese Food
- Giant ‘toothed’ birds flew over Antarctica 40 million to 50 million years ago
- Vote in favor of your #1 Sort of Convenience for a Family
- Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- 9 African migrants died in freezing temperatures near Morocco-Algeria border
- What's an atmospheric river? AP explains the weather phenomenon
